Discovery of Precision Oncology Drugs

NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com

Predictive Precision Medicine Platform for Ovarian Cancer

The poster presents a biomarker discovery platform using ascites of ovarian cancer patients. The aim is to develop a Precision Medicine Platform to predict the clinical response to chemo- and immunotherapy for epithelial ovarian cancer patients.